SynAm Vaccine

SynAm Vaccine

SynAm Vaccine`s mission is to eradicate pneumococcal diseases — pneumonia, middle ear infections, and meningitis — with the world`s first universal vaccine. Pneumococcal diseases are the leading cause of serious illness in children and adults throughout the world and account for more deaths than all other vaccine-preventable bacterial diseases combined. SynAm Vaccine`s lead universal vaccine candidate addresses the critical unmet medical need in the marketplace by providing universal coverage against all 91 bacteria serotypes, while current marketed vaccines cover only a fraction of the serotypes.

Company details

Rockville Innovation Center 155 Gibbs Street, #552,Rockville,20850

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Nationally (across the country)

Contact supplier

Drop file here or browse